| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |